Solventum Corp
SOLV · XNYSCIK 1964738fmd_1BER6T4AA8K43KEVCSAEKCGBHWManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2022 to Sep 30, 2026, 16 periods
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Rental revenue | 603 | 616 | 600 | 615 |
| Total revenues | 8,130 | 8,197 | 8,254 | 8,325 |
| Gross profit | 4,695 | 4,693 | 4,593 | 4,451 |
| Research and development | 767 | 758 | 775 | 739 |
| Selling, general and administrative | 2,235 | 2,299 | 2,782 | 3,080 |
| Operating income | 1,693 | 1,692 | 1,036 | 2,181 |
| Other non-operating income (expense) | (1) | (25) | (64) | (39) |
| Income before taxes | 1,692 | 1,667 | 605 | 1,713 |
| Income tax expense | 349 | 321 | 127 | 157 |
| Net income from continuing operations | 1,343 | 1,346 | 478 | 1,556 |
| Net income | 1,343 | 1,346 | 479 | 1,556 |